Cost-of-illness analyses for policy making: a cautionary tale of use and misuse

P Corso; Eric Finkelstein

doi:doi:10.1586/14737167.3.4.367

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

Cost-of-illness analyses for policy making: a cautionary tale of use and misuse

Finkelstein, E., & Corso, P. (2003). Cost-of-illness analyses for policy making: a cautionary tale of use and misuse. Expert Review of Pharmacoeconomics & Outcomes Research, 3(4), 367-369. https://doi.org/10.1586/14737167.3.4.367

Copy citation

Recent Publications

Article

Predictors of willingness to get a COVID-19 vaccine in the U.S

Article

Estimating regionalized planning costs of green infrastructure and low-impact development stormwater management practices

Article

Alpha-pyrrolidinopentiophenone and mephedrone self-administration produce differential neurochemical changes following short- or long-access conditions in rats

Cost-of-illness analyses for policy making: a cautionary tale of use and misuse

Publications Info

Recent Publications

Article

Predictors of willingness to get a COVID-19 vaccine in the U.S

Article

Estimating regionalized planning costs of green infrastructure and low-impact development stormwater management practices

Article

Alpha-pyrrolidinopentiophenone and mephedrone self-administration produce differential neurochemical changes following short- or long-access conditions in rats

OCCASIONAL PAPER

Perceived, experienced, and internalized cancer stigma